Skip to search.
 BSE Down 0.51% NSE Down 0.48%

More On AEZS

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Aeterna Zentaris Inc. (AEZS)

-NasdaqCM
2.85 Up 0.04(1.42%) 12 Feb 2:30am
Prev Close:2.81
Open:2.96
Bid:2.45 x 1000
Ask:3.22 x 500
1y Target Est:12.63
Beta:0.409425
Next Earnings Date:N/A
Day's Range:2.71 - 2.96
52wk Range:2.60 - 89.00
Volume:163,514
Avg Vol (3m):2,337,800
Market Cap:18.03M
P/E (ttm):N/A
EPS (ttm):-30.09
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for AEZS at this time.

Comparison

Symbol% ChgMkt Cap
AEZSUp 1.42%18.03M
CELGDown 3.46%78.24B
ENMD 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):39.16
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-2.18
Quarterly EPS Est (Dec-15) :-1.30
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women's health. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback